Stage IA Breast Cancer Terminated Phase 2 Trials for Methylene blue (DB09241)

IndicationStatusPhase
DBCOND0029217 (Stage IA Breast Cancer)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01276054Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.Supportive Care